Mir-320a as a potential novel circulating biomarker of arrhythmogenic cardiomyopathy

HIGHLIGHTS

• who: Elena Sommariva from the Performance Laboratory, Faculty of Kinesiology, University of Calgary, Calgary, Canada CeRiSM, Research have published the research work: MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy, in the Journal: Scientific Reports Scientific Reports of 13/Dec/2016
• what: The authors assessed miRNAs expression in plasma samples obtained from ACM and NON-ACM subjects.
• how: Data were analysed with the ExpressionSuite software v1.0.3 (Life Technologies) normalized by the Global Normalization method.
• future: It will be of interest to address in future studies any . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.